ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME. CAHIERS MAGELLANES-NS, [S. l.], v. 6, n. 2, p. 4972–4983, 2024. Disponível em: http://cahiersmagellanes.com/index.php/CMN/article/view/782.. Acesso em: 22 aug. 2025.